• In vitro effect of recombinant activated factor VII on thrombin generation and clot formation in blood from patients on vitamin K-antagonist therapy
• In vivo monitoring of haemophilia A patients with inhibitors under recombinant factor VIIa therapy

Friedrich U*, Larsen LF*, Lollike K*, Pyke C*, Tranholm M*, Johannessen M*, Nielsen JD**.
*Novo Nordisk A/S, Denmark. ** Coagulation Laboratory and Thrombosis Centre, Copenhagen County Hospital in Gentofte, Denmark
Journal of Thrombosis and Haemostasis 2003; 1 Supplement 1 July: P1120

Recombinant Factor VIIa
Monitoring

To top

Ute Friedrich1*, Lilian Tengborn ^{2, 3}, Ulla Hedner ^1
1Novo Nordisk A/S, Copenhagen, Denmark, 2Sahlgrenska Hospital, Gothenburg, Sweden, ³Malmö Hospital, Sweden
Journal of Thrombosis and Haemostasis 2003; 1 Supplement 1 July: P0633

Recombinant Factor VIIa
Monitoring

To top